Literature DB >> 6406893

Leydig-cell function in children after direct testicular irradiation for acute lymphoblastic leukemia.

R Brauner, P Czernichow, P Cramer, G Schaison, R Rappaport.   

Abstract

To assess the effect of testicular irradiation on testicular endocrine function, we studied 12 boys with acute lymphoblastic leukemia who had been treated with direct testicular irradiation 10 months to 8 1/2 years earlier. Insufficient Leydig-cell function, manifested by a low response of plasma testosterone to chorionic gonadotropin or an increased basal level of plasma luteinizing hormone (or both), was observed in 10 patients, 7 of whom were pubertal. Two of these patients had a compensated testicular endocrine insufficiency with only high plasma concentrations of luteinizing hormone. Testosterone secretion was severely impaired in three pubertal boys studied more than four years after testicular irradiation. A diminished testicular volume indicating tubular atrophy was found in all pubertal patients, including three who had not received cyclophosphamide or cytarabine. These data indicate that testosterone insufficiency is a frequent complication of testicular irradiation, although some patients continue to have Leydig-cell activity for several years after therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406893     DOI: 10.1056/NEJM198307073090106

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  11 in total

1.  Survival and endocrine outcome after testicular relapse in acute lymphoblastic leukaemia.

Authors:  R G Grundy; A D Leiper; R Stanhope; J M Chessells
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

2.  Leydig Cell Function in Male Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study.

Authors:  Wassim Chemaitilly; Qi Liu; Laura van Iersel; Kirsten K Ness; Zhenghong Li; Carmen L Wilson; Tara M Brinkman; James L Klosky; Nicole Barnes; Karen L Clark; Rebecca M Howell; Susan A Smith; Matthew J Krasin; Monika L Metzger; Gregory T Armstrong; Michael W Bishop; Hanneke M van Santen; Ching-Hon Pui; Deo Kumar Srivastava; Yutaka Yasui; Melissa M Hudson; Leslie L Robison; Daniel M Green; Charles A Sklar
Journal:  J Clin Oncol       Date:  2019-09-26       Impact factor: 44.544

Review 3.  Efficacy and toxicity of radiation in preparative regimens for pediatric stem cell transplantation. II: Deleterious consequences.

Authors:  T D Miale; S Sirithorn; S Ahmed
Journal:  Med Oncol       Date:  1996-03       Impact factor: 3.064

4.  Combined central precocious puberty and primary gonadal failure after treatment of childhood malignancy in two boys: a diagnostic and therapeutic conundrum.

Authors:  Zeina M Nabhan; Jakub Mieszczak; Erica A Eugster
Journal:  J Pediatr       Date:  2010-06-12       Impact factor: 4.406

Review 5.  Fertility preservation in men with cancer.

Authors:  Koji Chiba; Masato Fujisawa
Journal:  Reprod Med Biol       Date:  2014-04-26

Review 6.  Oncofertility and the male cancer patient.

Authors:  Landon W Trost; Robert E Brannigan
Journal:  Curr Treat Options Oncol       Date:  2012-06

7.  Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Daniel M Green; Toana Kawashima; Marilyn Stovall; Wendy Leisenring; Charles A Sklar; Ann C Mertens; Sarah S Donaldson; Julianne Byrne; Leslie L Robison
Journal:  J Clin Oncol       Date:  2009-11-30       Impact factor: 44.544

8.  Gonadal function after testicular radiation for acute lymphoblastic leukaemia.

Authors:  A D Leiper; D B Grant; J M Chessells
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

9.  Gonadal dysfunction after treatment of intracranial tumours.

Authors:  E A Livesey; C G Brook
Journal:  Arch Dis Child       Date:  1988-05       Impact factor: 3.791

10.  Effect of radiation on the human reproductive system.

Authors:  A L Ogilvy-Stuart; S M Shalet
Journal:  Environ Health Perspect       Date:  1993-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.